Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Skin Blood Flow in Patients With Type 1 Diabetes Mellitus Compared to Normal Controls

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Laura Armas, Creighton University
ClinicalTrials.gov Identifier:
NCT01592539
First received: May 3, 2012
Last updated: February 25, 2015
Last verified: February 2015

May 3, 2012
February 25, 2015
May 2012
August 2013   (final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT01592539 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Skin Blood Flow in Patients With Type 1 Diabetes Mellitus Compared to Normal Controls
Skin Blood Flow in Patients With Type 1 Diabetes Mellitus Compared to Normal Controls
The effects of high serum glucose on bone could be direct or could be indirect through its effects on the microvasculature. Previous studies by Rendell et al and Brugler et al have found significant differences in skin blood flow between diabetics and control. The investigators are proposing that blood flow measurements of the skin may be correlated with bone remodeling rates in iliac bone biopsies.
Not Provided
Observational
Observational Model: Case Control
Time Perspective: Cross-Sectional
Not Provided
Not Provided
Non-Probability Sample
Patients with Type 1 DM
  • Type 1 Diabetes,
  • Bone
Not Provided
  • Case
    Patients with Type 1 Diabetes Mellitus
  • Control
    Age and sex matched healthy controls.
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
78
August 2013
August 2013   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Must have completed a previous study.
Both
19 Years to 50 Years   (Adult)
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT01592539
Creighton11
No
Not Provided
Not Provided
Laura Armas, Creighton University
Creighton University
Not Provided
Principal Investigator: Laura AG Armas, MD Creighton University
Creighton University
February 2015

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP